Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A2JHC5 / Name: Aleafia Health Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Aleafia Health Inc. Stock

Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Aleafia Health Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Aleafia Health Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-29

Upon first inspection, Aleafia Health Inc.'s financial statements reveal a company facing considerable challenges and turbulence over the past few years. The financial performance demonstrates a decline in profitability as well as cash management difficulties.

Revenue Growth: The company has experienced revenue growth over time. For instance, total revenue increased from €16,351,000 in 2019 to €44,542,000 in 2020. This could be an indication of a growing market share and customer base for Aleafia Health Inc.

Decrease in Total Current Liabilities: The total current liabilities declined from €45,041,000 in 2020 to €37,580,000 in 2022, which is a positive sign for the company as it demonstrates improved short-term debt management.